Vanguard Capital Management »

Neuphoria Therapeutics shares owned by Vanguard Capital Management

Quarter-by-quarter ownership of Neuphoria Therapeutics (NEUP) shares owned by Vanguard Capital Management from 13F filings

Historical chart of Vanguard Capital Management investment in Neuphoria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neuphoria Therapeutics held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuphoria Therapeutics by Vanguard Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $758k 174k 4.37
2026-03-31 $401k 99k 4.07